09.10.2025 • News

Harke Pharma Acquires Groundbreaking Memory Complex

Harke Pharma has completed the acquisition of a highly acclaimed nutraceutical Memory Complex originally developed by Green Bioactives, UK.

Harke Pharma, based in Mülheim an der Ruhr, Germany, has completed the acquisition of a highly acclaimed nutraceutical Memory Complex originally developed by Green Bioactives, UK.

The Memory Complex is a patented combination of L-theanine and fructooli-gossaccharide, which Harke Pharma now has global control of. In a double-blinded placebo-controlled human clinical study1, the Memory Complex demonstrated an impressive improvement of 10.1% in total memory. This versatile ingredient can be incorporated into tablets, capsules, soft gels, sachets, gummies, bars, drinks, and syrups.

Christian Steinle, Head of Harke Nutra, one of the Business Units of Harke Pharma: “I am convinced by the scientifically proven combination of L-theanine and fructooligossaccharide, which naturally promotes cognitive performance. For me, our Memory Complex is a real booster for clear thinking and a strong memory.”

The newly acquired Memory Complex has already been commercialized by brands in Germany and the UK. Under Harke Pharma´s control it is expected to have further launches across Europe and North America over the next 12 months.

Company

Logo:

Harke Group GmbH

Xantener Str. 1
45479 Mülheim
Germany

Company contact







From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

most read